Jefferies Financial Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Sell |
5,189
-4,811
| -48% | -$227K | ﹤0.01% | 827 |
|
|
2025
Q1 | $391K | Buy |
10,000
+3,750
| +60% | +$147K | ﹤0.01% | 915 |
|
|
2024
Q4 | $338K | Buy |
+6,250
| New | +$338K | ﹤0.01% | 947 |
|
|
2024
Q2 | – | Sell |
-12,332
| Closed | -$619K | – | 1336 |
|
|
2024
Q1 | $619K | Buy |
12,332
+1,757
| +17% | +$88.3K | 0.01% | 723 |
|
|
2023
Q4 | $639K | Buy |
+10,575
| New | +$639K | ﹤0.01% | 778 |
|
|
2023
Q3 | – | Sell |
-93,789
| Closed | -$4.78M | – | 1310 |
|
|
2023
Q2 | $4.78M | Buy |
93,789
+24,076
| +35% | +$1.23M | 0.04% | 214 |
|
|
2023
Q1 | $1.49M | Buy |
69,713
+2,059
| +3% | +$44K | 0.01% | 451 |
|
|
2022
Q4 | $710K | Buy |
+67,654
| New | +$710K | ﹤0.01% | 576 |
|